After taking a two-week break, I return right when the Berkshire Hathaway weekend is fast approaching. I was going to attend the meeting – my fourth – but couldn’t, so during the weekend I’ll point our readers to the best 3rd-party sources out there. This year’s meeting is bound to be very interesting with questions on IBM, Ted Weschler and so on, but obviously the main issue will be succession. Buffett’s announcement that he has stage 1 prostate cancer is definitely in the news – this article by the WSJ, H/T Century Partners, is relatively complete – but as in all things involving Berkshire & Buffett it gets blown out of proportion. Hopefully the weekend’s interviews will shed light on more relevant factors such as the existence of a succession plan, the strength of Berkshire’s culture and the role of the Board in these matters. No, cancer is never to be taken lightly, but it isn’t yet a sign of impending retirement.